comparemela.com

Cardiff Oncology Company Profile News Today : Breaking News, Live Updates & Top Stories | Vimarsana

HC Wainwright Reiterates Buy Rating for Cardiff Oncology (NASDAQ:CRDF)

HC Wainwright Reiterates Buy Rating for Cardiff Oncology (NASDAQ:CRDF)
dailypolitical.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailypolitical.com Daily Mail and Mail on Sunday newspapers.

Cardiff Oncology s (CRDF) Buy Rating Reiterated at HC Wainwright

Cardiff Oncology s (CRDF) Buy Rating Reiterated at HC Wainwright
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Cardiff Oncology (CRDF) Scheduled to Post Earnings on Thursday

Cardiff Oncology (NASDAQ:CRDF – Get Free Report) will be posting its quarterly earnings results after the market closes on Thursday, May 2nd. Analysts expect Cardiff Oncology to post earnings of ($0.25) per share for the quarter. Individual interested in participating in the company’s earnings conference call can do so using this link. Cardiff Oncology (NASDAQ:CRDF […]

Insider Buying: Cardiff Oncology, Inc (NASDAQ:CRDF) Director Acquires 30,000 Shares of Stock

Insider Buying: Cardiff Oncology, Inc (NASDAQ:CRDF) Director Acquires 30,000 Shares of Stock
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Cardiff Oncology, Inc (NASDAQ:CRDF) Short Interest Down 9 4% in November

Cardiff Oncology, Inc. (NASDAQ:CRDF – Get Free Report) was the recipient of a significant decrease in short interest in November. As of November 30th, there was short interest totalling 1,450,000 shares, a decrease of 9.4% from the November 15th total of 1,600,000 shares. Based on an average daily trading volume, of 688,500 shares, the short-interest […]

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.